Key details
Collaborators
Peking University Cancer Hospital & Institute, Changzhi People's Hospital
Enrollment target
~1,036 participants
Primary completion
July 2023
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated December 2021